《iLIVER》

作品数:112被引量:51H指数:3
导出分析报告
《iLIVER》
主办单位:清华大学
最新期次:2024年4期更多>>
发文主题:HEPATOCELLULAR_CARCINOMALIVERHEPATOCELLULARLIVER_CANCERPATIENTS更多>>
发文领域:医药卫生自动化与计算机技术文化科学更多>>
发文基金:国家自然科学基金湖北省自然科学基金北京市自然科学基金国家重点基础研究发展计划更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
WGCNA combined with machine learning to explore potential biomarkers and treatment strategies for acute liver failure,with experimental validation
《iLIVER》2024年第4期44-55,共12页Xinyan Wu Xiaomei Zheng Gang Ye 
Background and aims:To identify biomarkers to predict acute liver failure and investigate the mechanisms and immune-related pathways linked to its onset and progression.Methods:We analyzed gene expression differences ...
关键词:Acute liver failure Machine learning Eriodictyol Potential biomarker Weighted gene co-expression network analysis Differential gene expression analysis 
Danning tablets for the treatment of multiple gallbladder polyps: Study protocol of multicentre, randomised, open-labelled, controlled trial
《iLIVER》2024年第4期56-61,共6页Tian Yang Ming-Da Wang Gui-Lin Xie Xiong-Hua Wang Liu Zheng Li-Min Wang Guang-Fa Xiao Yong-Qing Yang Chao Li Alfred Wei Chieh Kow Feng Shen 
funding from Shanghai Hutchison Pharmaceuticals Company.
Introduction:Gallbladder polyps(GPs)are protrusions of the gallbladder wall into the lumen,and are commonly detected during ultrasound examinations.Traditional management of multiple GPs(MGPs)has been conservative,inc...
关键词:Multiple gallbladder polyps Danning tablets SIZE Lifestyle intervention 
Increased attention to women with drug-induced liver injury:Risk factors and early intervention
《iLIVER》2024年第4期62-63,共2页Xiaoru Sun Xinrong Zhang Muyun Liu 
supported by Shanghai Rising Star of Medical Talents Youth Development Program(Grant No.SHWSRS(2023));Shanghai Changning District Health Commission Youth Project(Grant No.2023QN27).
A recent study by Xiong Yu-Ting and colleagues has unveiled the clinical characteristics and risk factors of acute drug-induced liver injury(DILI).Upon reading the article,we found that there are some differences betw...
关键词:liver DRUG FEMALE 
Comment on“Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab”
《iLIVER》2024年第4期64-65,共2页Binghua Li Qiang Wang Weiwei Hu Huan Li Peng Yan Yajuan Cao Decai Yu 
supported by grants from the National Natural Science Foundation of China(Nos.82372834 and 82173129);the Jiangsu Outstanding Youth Foundation(BK20240119).
We read with great interest the recent article by Shen et al.[1],which provides valuable insights into the outcomes and histopathologic characteristics of hepatocellular carcinoma(HCC)patients treated with atezolizuma...
关键词:(PCR) PATIENTS HEPATOCELLULAR 
Full robotic whole graft liver transplantation:Is a new era coming?
《iLIVER》2024年第4期66-67,共2页Yipeng Pan Jimin Liu Qi Ling 
With great interest,we read the article conducted by Pinto-Marques H et al.,entitled“Full Robotic Whole Graft Liver Transplantation:A Step Into The Future”[1],which was published in the current issue of Annals of Su...
关键词:ROBOTIC ROBOTIC WHOLE 
Reply to Dr.Sun et al.:Female DILI patients need more clinical attention
《iLIVER》2024年第4期68-69,共2页Yu-Ting Xiong Chun-Yan Wang Dong Ji 
funded by Capital’s Funds for Health Improvement and Research of Beijing Municipal Health Commission(2024-2-5068);PLA General Hospital Youth Independent Innovation Science Fund project(22QNCZ023).
Dear editor,We are writing to give a response to the article titled“Focusing on women with DILI and their outcomes,appropriately intervening early”(Sun X et al.,2024)recently published in your journal.The article fo...
关键词:DILI METABOLISM 
Multiomic predictors for regression of cirrhosis:Clinical implications and future directions
《iLIVER》2024年第4期1-2,共2页Binghua Li Decai Yu 
supported by grants from the National Natural Science Foundation of China(No.82372834 and 82173129).
Advanced chronic liver disease(ACLD)can lead to fibrosis,cirrhosis,and eventually hepatocellular carcinoma(HCC)[1].Hepatic fibrosis is characterized by formation of a fibrous scar because of accumulation of extracellu...
关键词:Cirrhosis regression Multiomics Advanced chronic liver disease BIOMARKER Lipid metabolism 
Speaking the same language in predicting Small-for-Size Syndrome in living donor liver transplantation
《iLIVER》2024年第4期3-6,共4页Alfred Wei-Chieh Kow 
Small-for-Size Syndrome(SFSS)has emerged to be a critical challenge in living donor liver transplantation(LDLT)as the procedure involves utilisation of partial(therefore,smaller)liver grafts compared to whole liver gr...
关键词:LIVER DONOR MORTALITY 
Arginine methylation modification in the malignant progression of benign and malignant liver diseases
《iLIVER》2024年第4期7-14,共8页Jie-Zuo Huang Bei-Ning Qiao Dang-Chi Li Qiu-Rong Wei Zi-Jian Zhang 
financially supported by the Natural Science Foundation of Hunan Province,China(Grant No.2023JJ50014).
The role of protein arginine methyltransferases(PRMTs)in benign and malignant liver diseases has garnered considerable attention.PRMTs play a key function in regulating protein methylation modification in diseases suc...
关键词:METABOLISM Therapeutic strategies Arginine methyltransferases Liver diseases Alcoholic liver disease Non-alcoholic liver disease Metabolic dysfunction–associated steatotic liver disease Viral hepatitis Hepatocellular carcinoma 
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products
《iLIVER》2024年第4期15-23,共9页Pooja Yadav Khushi Quadri Renu Kadian Aafrin Waziri Pankaj Agrawal Md Sabir Alam 
Metabolic dysfunction-associated steatotic liver disease(MASLD)is a widespread and potentially severe liver condition characterized by abnormal fat accumulation in the liver unrelated to alcohol consumption.According ...
关键词:MASLD Natural products Alcohol consumption Liver disorder THERAPY 
检索报告 对象比较 聚类工具 使用帮助 返回顶部